Favivir 200mg Tablet is an anti-viral medication and a derivative of pyrazinecarboxamide and has been authorized to treat COVID-19 in several countries. Favipiravir 200mg is a molecule/drug content in Favivir, it is a nucleoside analogue and mimics guanosine and adenosine.
It is a prodrug metabolized to its active form which is available in both oral and intravenous formulations.
Favipiravir acts as an active inhibitor of viral RNA-dependant RNA polymerase, and approved that it treats novel influenza.
Favipiravir medicine is an investigational product to treat COVID 19, but it does not necessarily treat the virus by avoiding duplication of infections that replicate virus.
RNA polymerase is the enzyme that aids SARS-CoV-2 to make new RNA and thus virus in the body increases, Favivir targets the enzyme selectively and inhibits the replication of virus causing COVID 19.
The medicine is not recommended to pregnant women, planning for pregnancy, breastfeeding mothers unless in avoidable conditions.
Intake plenty of fluids and ORS to avoid dehydration.
Swallow the tablet as a whole, do not crunch, chew, or split the tablet.
Do not drive or operate heavy machinery as the medicine makes gives drowsiness and sleepiness.
Tell your doctor if you have medical history of heart, lungs, history of gout or hyperuricemia, and kidneys. If you are allergic to ingredients of Favivir.